Free Test Strips and Blood Glucose Control

This study has been completed.
Sponsor:
Information provided by:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00205335
First received: September 13, 2005
Last updated: November 21, 2008
Last verified: November 2008
  Purpose

This study is designed to determine if there is an impact on blood glucose control in patients who receive free test strips. Patients in the study have no insurance or insurance that does not cover the purchase of test strips. A comparison of weight, blood pressure, and Hemoglobin A1C from entry to the final visit will be used to compare patients' management of their diabetes. Recommended values for these parameters will be used as the standard for comparisons. The investigators anticipate that patients receiving free test strips will show an improvement in the listed parameters as well as in satisfaction with their care.


Condition Intervention
Diabetes
Device: Ascencia Breeze Glucose meter
Device: Breeze Glucose Monitor (Bayer)

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: The Impact of Increased Availability of Test Strips on Blood Glucose Control in Patients With Diabetes

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Weight [ Time Frame: one year ] [ Designated as safety issue: No ]
  • Blood pressure [ Time Frame: one year ] [ Designated as safety issue: No ]
  • Hemoglobin A1C [ Time Frame: one year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Satisfaction with care [ Time Frame: one year ] [ Designated as safety issue: No ]

Enrollment: 22
Study Start Date: January 2004
Study Completion Date: November 2007
Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
glucose monitoring
Each participant received a Bayer Breeze Monitor and glucose test strips for monitoring blood sugar.
Device: Ascencia Breeze Glucose meter
All study participants received glucose meter and test strips.
Other Name: Ascencia Breeze glucose meters made by Bayer and test strips
Device: Breeze Glucose Monitor (Bayer)
Each participant received a Breeze monitor and glucose test strips.
Other Name: Ascencia Breeze Glucose Meter, Bayer

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with a diagnosis of diabetes who have no health insurance or insurance that does not pay for purchase of blood test strips

Exclusion Criteria:

  • Patients with a diagnosis of diabetes who have health insurance that pays for purchase of blood test strips
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00205335

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: Sherree Drezner, ACSW, LCSW University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: Eileen Dalebroux, RN, CDE, University of Wisconsin Hospital and Clinics
ClinicalTrials.gov Identifier: NCT00205335     History of Changes
Other Study ID Numbers: 2004-1069
Study First Received: September 13, 2005
Last Updated: November 21, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on April 23, 2014